Free Trial

Covalon Technologies (CVALF) Stock Price, News & Analysis

-0.03 (-4.05%)
(As of 05/24/2024 08:51 PM ET)
Today's Range
50-Day Range
52-Week Range
2,500 shs
Average Volume
4,719 shs
Market Capitalization
$19.36 million
P/E Ratio
Dividend Yield
Price Target
CVALF stock logo

About Covalon Technologies Stock (OTCMKTS:CVALF)

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity. It also offers medical coating platform, a process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device. In addition, the company provides wound care dressings; surgical and peri-operative; and infection management products. It offers its products under the Covalon brand name through third-party distribution networks and company's direct sales force. The company serves hospitals, wound care centers, burn centers, extended/alternate care and acute care facilities, home health care agencies, and physicians' offices. Covalon Technologies Ltd. is headquartered in Mississauga, Canada.

CVALF Stock Price History

CVALF Stock News Headlines

Covalon Announces First Quarter Fiscal 2024 Results
Covalon Announces Leadership Changes
Covalon Announces Third Quarter Fiscal 2023 Results
See More Headlines
Receive CVALF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Covalon Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Fiscal Year End

Industry, Sector and Symbol

Health services
Current Symbol
Year Founded


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
$19.72 million
Book Value
$0.56 per share


Free Float
Market Cap
$19.36 million
Not Optionable
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. Ronald Hebert
    Senior Vice President of Growth
  • Mr. Amir Boloor CFA
    Executive Chairman
  • Mr. Brent Ashton
    CEO & Director
  • Dr. Valerio DiTizio (Age 56)
    Co-Founder, Chief Scientific Officer & VP
    Comp: $128.97k
  • Ms. Katie Martinovich
    Interim Chief Financial Officer
  • Ms. Kim Crooks
    Senior Vice President of Operations
  • Mr. Greg Leszczynski
    Vice President of Human Resources
  • Gerry Arambula
    President of Covalon Technologies AG Ltd.
  • Mr. Hamed Abbasian
    Vice President of Business Development
  • Emily Hill
    Executive Assistant to the CEO

CVALF Stock Analysis - Frequently Asked Questions

How have CVALF shares performed in 2024?

Covalon Technologies' stock was trading at $0.77 at the start of the year. Since then, CVALF shares have increased by 0.3% and is now trading at $0.7724.
View the best growth stocks for 2024 here

Are investors shorting Covalon Technologies?

Covalon Technologies saw a drop in short interest during the month of April. As of April 30th, there was short interest totaling 1,000 shares, a drop of 80.0% from the April 15th total of 5,000 shares. Based on an average daily volume of 3,000 shares, the short-interest ratio is currently 0.3 days.
View Covalon Technologies' Short Interest

How were Covalon Technologies' earnings last quarter?

Covalon Technologies Ltd. (OTCMKTS:CVALF) released its quarterly earnings data on Wednesday, February, 28th. The company reported ($0.02) earnings per share (EPS) for the quarter. The firm had revenue of $3.43 million for the quarter. Covalon Technologies had a negative trailing twelve-month return on equity of 24.83% and a negative net margin of 19.70%.

How do I buy shares of Covalon Technologies?

Shares of CVALF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CVALF) was last updated on 5/27/2024 by Staff

From Our Partners